Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC4XD.L Regulatory News (C4XD)

  • There is currently no data for C4XD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

3 Apr 2017 17:22

RNS Number : 4402B
C4X Discovery Holdings PLC
03 April 2017
 

 

For filings with the FCA include the annex

For filings with issuer exclude the annex

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

C4X Discovery Holdings Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

X

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

THE AQUARIUS IV FUND LLP

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

03 April 2017

6. Date on which issuer notified:

03 April 2017

7. Threshold(s) that is/are crossed orreached: vi, vii

11%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

 

Ordinary Shares

GB00BQQ2RV18

4,864,375

4,864,375

4,864,375

4,864,375

10.66%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

4,864,375

10.66%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

DUNCAN PEYTON

15. Contact telephone number:

07879 408000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLLLFFRSIIVIID
Date   Source Headline
7th Dec 20204:05 pmRNSC4X Discovery Notice of Results
12th Nov 202012:32 pmRNSHolding(s) in Company
12th Nov 202011:36 amRNSHolding(s) in Company
12th Nov 20209:14 amRNSHoldings in Company
11th Nov 20206:12 pmRNSHoldings in Company
11th Nov 20204:44 pmRNSHolding(s) in Company
9th Nov 202011:24 amRNSResult of General Meeting and Issue of Equity
21st Oct 20203:54 pmRNSResult of Placing
21st Oct 20207:06 amRNSProposed Placing
10th Sep 202010:18 amRNSHolding(s) in Company
2nd Sep 202010:19 amRNSHolding(s) in Company
25th Aug 20207:00 amRNSBusiness Update
18th Aug 202011:05 amRNSSecond Price Monitoring Extn
18th Aug 202011:00 amRNSPrice Monitoring Extension
29th Jul 20202:54 pmRNSCancellation and Regrant of Existing Share Options
21st Jul 20202:02 pmRNSHoldings in Company
5th Jun 20207:00 amRNSClive Dix appointed to the UK Vaccine Taskforce
13th May 20203:28 pmRNSHoldings in Company
12th May 20206:23 pmRNSHolding(s) in Company
12th May 20202:02 pmRNSHolding(s) in Company
7th May 202012:36 pmRNSResult of Placing
7th May 20207:00 amRNSProposed Placing
29th Apr 20209:00 amRNSPrice Monitoring Extension
29th Apr 20207:00 amRNSInterim results
28th Apr 20204:41 pmRNSSecond Price Monitoring Extn
28th Apr 20204:37 pmRNSPrice Monitoring Extension
24th Apr 20207:00 amRNSNotice of Results
30th Mar 20202:06 pmRNSSecond Price Monitoring Extn
30th Mar 20202:01 pmRNSPrice Monitoring Extension
31st Jan 202012:24 pmRNSResult of AGM
17th Jan 20209:00 amRNSNotice of AGM and Posting of 2019 Annual Report
7th Jan 20207:00 amRNSFull Year Results
12th Dec 201911:04 amRNSNotice of Full Year Results
9th Dec 20191:20 pmRNSAltasciences appointed by Indivior
5th Dec 20192:24 pmRNSGrant of Options
19th Nov 20193:38 pmRNSDirector Dealings
19th Nov 20197:00 amRNSHoldings in Company
18th Nov 20193:02 pmRNSHoldings in Company
18th Nov 20193:00 pmRNSHoldings in Company
18th Nov 20192:58 pmRNSHoldings in Company
13th Nov 201911:21 amRNSResult of General Meeting
24th Oct 20194:40 pmRNSSecond Price Monitoring Extn
24th Oct 20194:35 pmRNSPrice Monitoring Extension
24th Oct 20194:02 pmRNSResults of Placing
24th Oct 20197:00 amRNSProposed Placing, Subscription and Open Offer
1st Oct 20197:00 amRNSBusiness update
27th Sep 20194:41 pmRNSSecond Price Monitoring Extn
27th Sep 20194:35 pmRNSPrice Monitoring Extension
27th Sep 20199:40 amRNSIndivior awarded NIH HEAL grant for C4X3256
2nd Sep 20197:00 amRNSC4XD forms Drug Discovery Advisory Network

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.